Acetoacetic Acid

Acetoacetic Acid

SCHEMBL1864033

C=CO.CC(=O)CC(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
KDM5C P41229 2/20 0.44
EGLN1 Q9GZT9 2/20 0.44
PHF8 Q9UPP1 2/20 0.44
KDM2A Q9Y2K7 2/20 0.44
KDM6B O15054 1/20 0.44
LDHA P00338 1/20 0.42
SRR Q9GZT4 1/20 0.42
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 2/20 0.39
SLC15A2 Q16348 1/20 0.39
ALDH1A1 P00352 4/20 0.38
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
HTT P42858 1/20 0.35
TSHR P16473 2/20 0.33
FFAR3 O14843 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetoacetic Acid SCHEMBL23581266 0.89 KDM4E (0.44) KDM4EKDM5CEGLN1PHF8KDM2A
Acetoacetic Acid SCHEMBL30758649 0.89 KDM4E (0.44) KDM4EKDM5CEGLN1PHF8KDM2A
Acetoacetic Acid SCHEMBL1023325 0.86 ALOX15 (0.56) KDM4EKDM5CEGLN1PHF8KDM2A
Acetoacetic Acid SCHEMBL7747946 0.86 ALOX15 (0.56) KDM4EKDM5CEGLN1PHF8KDM2A
Acetoacetic Acid SCHEMBL7441846 0.86 KDM4E (0.46) KDM4EKDM5CEGLN1PHF8KDM2A
Acetoacetic Acid SCHEMBL447678 0.85
Acetoacetic Acid SCHEMBL10448884 0.85
Acetoacetic Acid SCHEMBL10941648 0.85 LDHA (0.57) KDM4EKDM5CEGLN1PHF8KDM2A
Acetoacetic Acid SCHEMBL21402364 0.85
Acetoacetic Acid SCHEMBL1406366 0.85 LDHA (0.57) KDM4EKDM5CEGLN1PHF8KDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8790632-B2 Polymer-based tissue-adhesive form medical use ACTAMAX SURGICAL MATERIALS, LLC (US) 2014-07-29 US disclosed
EP-1796745-B1 POLYMER-BASED TISSUE-ADHESIVE FOR MEDICAL USE DU PONT (US) 2011-05-25 EP disclosed
EP-1749845-B1 Composite materials and methods of making the same ROHM & HAAS (US) 2008-10-01 EP disclosed
EP-1796745-A2 POLYMER-BASED TISSUE-ADHESIVE FOR MEDICAL USE E.I.Du pont de nemours and company (US) 2007-06-20 EP disclosed
US-20070032576-A1 Composite materials and methods of making the same LUNDQUIST ERIC G 2007-02-08 US disclosed
EP-1749845-A1 Composite materials and methods of making the same Rohm and Haas Company (US) 2007-02-07 EP disclosed
WO-2006042169-A2 POLYMER-BASED TISSUE-ADHESIVE FOR MEDICAL USE E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-04-20 WO disclosed
US-20060079599-A1 Polymer-based tissue-adhesive form medical use ACTAMAX SURGICAL MATERIALS, LLC 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079599-A1 Polymer-based tissue-adhesive form medical use ADSL, SI, VCAM1 KDM4E 1780/4885KDM5C 2721/4885EGLN1 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.